Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009
|
Luke Timmerman |
09/22/09 |
Seattle
|
|
Celladon, Developer of Gene Therapy for Heart Failure, Secures Part of $24.6M Venture Round
|
Luke Timmerman |
09/15/09 |
San Diego
|
|
Arena Prepares to Release Big Obesity Study, Minnow Medical Goes Into ‘Commercialization Mode,’ Metabasis Hires Strategic Adviser, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
09/10/09 |
San Diego
|
|
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Targeted Genetics Survives Brush With Death, Sells Gene Therapy IP to Genzyme for $7M
|
Luke Timmerman |
09/09/09 |
National
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
Biotechs Go Back to the Future by Re-Innovating Old Drugs
|
Denise Gellene |
08/26/09 |
San Diego
|
|
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies
|
Luke Timmerman |
08/25/09 |
Seattle
|
|
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/13/09 |
Seattle
|
|
Targeted ‘Must Raise’ Cash
|
Luke Timmerman |
08/12/09 |
Seattle
|
|
Seattle Layoff Update: Targeted Genetics, Wetpaint, Google, and Others Cut Staff
|
Gregory T. Huang |
07/27/09 |
Seattle
|
|
Targeted Genetics Amends Lease
|
Luke Timmerman |
07/24/09 |
Seattle
|
|
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/09/09 |
Seattle
|
|
Targeted Genetics Sheds Lease
|
Luke Timmerman |
07/06/09 |
Seattle
|
|
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News
|
Luke Timmerman |
06/25/09 |
Seattle
|
|
Targeted Genetics Cuts Workforce in Half in Bid to Survive Into August
|
Luke Timmerman |
06/22/09 |
Seattle
|
|
Amylin Dissidents Win Board Seats, Targeted Genetics’ Troubles Raise Gene Therapy Concerns, Celladon Eyes Partnership, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
06/04/09 |
San Diego
|
|
Experimental Gene Therapy for Blindness Will Proceed Even if Targeted Genetics Goes Dark
|
Denise Gellene |
06/03/09 |
San Diego
|
|
Can the Feds Get Into the Biotech VC Business? Bionager Wants to Make It Happen
|
Luke Timmerman |
05/29/09 |
Seattle
|
|
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown
|
Luke Timmerman |
05/07/09 |
Seattle
|
|
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/02/09 |
Seattle
|
|
Targeted Ends Year With $5.2M
|
Luke Timmerman |
03/31/09 |
Seattle
|
|
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days
|
Luke Timmerman |
03/25/09 |
Boston
|
|
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn
|
Luke Timmerman |
03/25/09 |
Seattle
|
|
Friend Leads Open Source Biology Push, Arzeda Leaves UW Nest, SBRI Teams with PATH on Malaria, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
03/05/09 |
Seattle
|
|
Targeted Genetics Hands Off Manufacturing
|
Luke Timmerman |
03/02/09 |
Seattle
|
|
Life Sciences on a Budget: Startups Make Pitch for Angel Dollars at First Zino Society Forum
|
Luke Timmerman |
02/25/09 |
Seattle
|
|
Hey, Don’t Forget the Puget Sound Life Sciences Universe!
|
Luke Timmerman |
02/09/09 |
Seattle
|
|
Biotech “Walks With Light,” But If We Don’t Start Explaining it Better, We’re “Cuckoo”
|
H. Stewart Parker |
12/22/08 |
National
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
